Pharmacogenomics is the study of how inherited variations in genes dictate a person's reaction to a drug. In this 2004 to 2005 project, Louis F. Rossiter, PhD, and other researchers from the College of William & Mary Center for Public Policy Research, examined how pharmacogenomics fits within the current health care market.
This project was part of the Robert Wood Johnson Foundation (RWJF) national program Changes in Health Care Financing and Organization (HCFO). HCFO supports policy analysis, research, evaluation and demonstration projects that provide public and private decision leaders with usable and timely information on health care policy and financing issues.
The researchers reported the following findings: